Advances in the application of insulin resistance-related indicators in the clinical evaluation of metabolic dysfunction-associated steatotic liver disease. [PDF]
Li Y, Li H, Zhang B, Wu Q, Long H.
europepmc +1 more source
Association of MASLD with chronic kidney disease according to metabolic profiles and fibrosis severity: a KNHANES analysis. [PDF]
Park HJ, Kim SW.
europepmc +1 more source
ABSTRACT Aims This study quantified the real‐world healthcare costs and utilisation associated with diagnosed metabolic dysfunction‐associated steatotic liver disease (MASLD) among adults with Type 2 diabetes (T2D). Methods We conducted a retrospective cohort study using IQVIA PharMetrics Plus Closed Health Plan data from January 2016 to June 2025 ...
Tien Hoang Tran +3 more
wiley +1 more source
Association between low skeletal muscle mass assessed by deep learning-based CT and MASLD: a prospective cohort study. [PDF]
Wang Y +11 more
europepmc +1 more source
Name MASLD/MASH — and act on it
Lazarus, Jeffrey V. +5 more
openaire +4 more sources
ABSTRACT Aims Adults with obesity are at increased risk of metabolic dysfunction‐associated steatotic liver disease (MASLD)‐related fibrosis, but the diagnostic performance of non‐invasive tests (NITs) in this population remains uncertain. This meta‐analysis evaluated NITs for detecting significant (≥F2) and advanced (≥F3) fibrosis in adults with ...
Patricia M. Ortega +5 more
wiley +1 more source
Epidemiology, temporal trends, and fibrosis risk stratification in metabolic dysfunction-associated steatotic liver disease in UK primary care: a population-based cohort and nested case-control study. [PDF]
Huang HT +5 more
europepmc +1 more source
ABSTRACT Aims To investigate associations of cardiorespiratory fitness (CRF) with metabolic syndrome (MetS) trait count, MetS prevalence and individual MetS traits in a large population‐based cohort. Materials and Methods This cross‐sectional study analysed data for 39 197 adults from a UK‐based independent healthcare charity (mean ± SD: age, 45.8 ± 9 ...
Scott A. Willis +13 more
wiley +1 more source
<i>Bacteroides cellulosilyticus</i>-derived 2-hydroxyphenylacetic acid rectifies hepatic lipid homeostasis in MASLD by targeting the PPARγ-CD36 axis. [PDF]
Chen K +21 more
europepmc +1 more source
Editorial on “Genome-wide interaction study with body mass index identifies CYP7A1 and GIPR as genetic modulators of metabolic dysfunction-associated steatotic liver disease” [PDF]
Julia Kozlitina
doaj +1 more source

